Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rectal Indomethacin for Post-ERCP Pancreatitis Prevention
NCT01912716Phase 3Completed
- Sponsor
- Indiana University
- Start
- Jul 2013
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of indomethacin in post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP), sponsored by Indiana University. Started Jul 2013; status: completed.
02
Drugs
indomethacin
03
Conditions
post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP)
Beyond the preview
Go deeper on NCT01912716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01912716.